Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Stevia Nutra Corp STNT

Consumer Defensive Farm Products
Stevia Nutra Corp is engaged in the business of cultivation, development, and post-harvest processing of Stevia plants for use as a sweetener. It provides raw stevia to wholesalers and manufacturers who create a wide range of products for consumption. It is also into producing Hemp.

Recent & Breaking News (GREY:STNT)

STENTYS: Convening of Another Annual General Meeting on June 16, 2016

Business Wire May 12, 2016

STENTYS : convocation à une nouvelle Assemblée générale ordinaire annuelle le 16 juin 2016

Business Wire May 12, 2016

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

Business Wire June 4, 2014

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

Business Wire May 27, 2014

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients

Business Wire May 20, 2014

STENTYS Secures a Standby Equity Facility

Business Wire May 14, 2014

STENTYS: Journal of the American College of Cardiology Publication Shows Malapposition Influences Death from Early Stent Thrombosis

Business Wire May 6, 2014

STENTYS' Self-Apposing Stent Featured in New Article Published by the Journal of the American College of Cardiology

Business Wire April 29, 2014

STENTYS: First Quarter Revenues Up 18% from 2013

Business Wire April 24, 2014

STENTYS Appoints Medical Device Executive to its Board of Directors

Business Wire April 10, 2014

STENTYS Reports 2013 Financial Results

Business Wire March 13, 2014

STENTYS 2013 Annual Revenues Up 34% From 2012

Business Wire January 23, 2014

STENTYS Expands Marketing of its Stents in Asia

Business Wire January 8, 2014

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

Business Wire October 30, 2013

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

Business Wire October 29, 2013

STENTYS Revenues for the First 9 Months of 2013 Up 32% Over Prior Year

Business Wire October 24, 2013

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

Business Wire October 21, 2013

STENTYS Reports H1 2013 Financial Results

Business Wire August 29, 2013

STENTYS Revenues for the First Half of 2013 Up 43% Over Prior Year

Business Wire July 25, 2013

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications

Business Wire July 10, 2013